mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.004 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
CHEMBL1222381 |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.005 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.008 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.009 |